ArticleScientific reports2025
Knowledge, attitude, and practice toward antiviral treatment of chronic hepatitis B among patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
China has the largest number of hepatitis B patients globally, making early detection, intervention, and treatment crucial. This study assessed the knowledge, attitude, and practice (KAP) toward antiviral treatment among chronic hepatitis B (CHB) patients. A web-based cross-sectional study was conducted among hepatitis B patients at the author's Hospital, Tianjin, China, between October 2022 and January 2023. Primary outcomes were KAP scores (knowledge: 0-18, attitude: 0-35, practice: 0-50). Secondary outcomes included factors associated with KAP. A total of 457 hepatitis B patients participated. The Mean KAP scores were 9.70 ± 4.64 (knowledge), 24.00 ± 3.28 (attitude), and 38.85 ± 6.56 (practice). Factors independently associated with adequate knowledge included household income 5,000-10,000 CNY (OR = 1.81, 95%CI: 1.05-3.12; positive factor), > 10,000 CNY (OR = 2.05, 95%CI: 1.01-4.17; positive factor), rural cooperative medical insurance (OR = 0.5, 95%CI: 0.27-0.94; negative factor), carrier-stage hepatitis B (OR = 0.34, 95%CI: 0.13-0.91; negative factor), and treatment > 10 years (OR = 2.74, 95%CI: 1.09-6.88; positive factor). Positive attitude was associated with income > 10,000 CNY (OR = 2.77, 95%CI: 1.41-5.44; positive factor) but negatively with cirrhosis (OR = 0.43, 95%CI: 0.24-0.76; negative factor) and liver cancer (OR = 0.19, 95%CI: 0.05-0.71; negative factor). Knowledge (OR = 1.20, 95%CI: 1.13-1.27) was independently associated with a proactive practice, while female sex (OR = 0.58, 95%CI: 0.35-0.95) and use to drink (OR = 0.43, 95% CI: 0.22-0.82) were independently associated with worse practice. CHB patients demonstrated suboptimal KAP levels regarding antiviral therapy. Policy support should prioritize low-income populations to improve treatment adherence and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.